Clinical Trials

Blaze is focused on developing Tumor Paint products and related therapeutics. Our first Tumor Paint product candidate, BLZ-100, is being developed for brain cancer surgery. Below is more information on our current clinical trial for BLZ-100.
​
BLZ-100: Pediatric brain cancer (U.S.)
Title:  A Randomized, Blinded Study of Fluorescence Detection of Pediatric Primary Central Nervous System Tumors in Subjects Receiving Tozuleristide and Imaged With the Canvas System
Status: Recruiting
More information: For a link to the clinicaltrials.gov site, please click here.